These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 10722616)

  • 1. Survival of group B streptococcus type III in mononuclear phagocytes: differential regulation of bacterial killing in cord macrophages by human recombinant gamma interferon and granulocyte-macrophage colony-stimulating factor.
    Maródi L; Káposzta R; Nemes E
    Infect Immun; 2000 Apr; 68(4):2167-70. PubMed ID: 10722616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines enhance opsonophagocytosis of type III group B Streptococcus.
    Campbell JR; Edwards MS
    J Perinatol; 2000 Jun; 20(4):225-30. PubMed ID: 10879334
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction by interferons of human eosinophil apoptosis and regulation by interleukin-3, granulocyte/macrophage-colony stimulating factor and interleukin-5.
    Morita M; Lamkhioued B; Soussi Gounni A; Aldebert D; Delaporte E; Capron A; Capron M
    Eur Cytokine Netw; 1996 Dec; 7(4):725-32. PubMed ID: 9010674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Augmentation of human macrophage candidacidal capacity by recombinant human myeloperoxidase and granulocyte-macrophage colony-stimulating factor.
    Maródi L; Tournay C; Káposzta R; Johnston RB; Moguilevsky N
    Infect Immun; 1998 Jun; 66(6):2750-4. PubMed ID: 9596743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recombinant granulocyte-macrophage colony-stimulating factor activates human macrophages to inhibit growth or kill Mycobacterium avium complex.
    Bermudez LE; Young LS
    J Leukoc Biol; 1990 Jul; 48(1):67-73. PubMed ID: 2113563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic use of recombinant human granulocyte-macrophage colony-stimulating factor in neonatal rats with type III group B streptococcal sepsis.
    Wheeler JG; Givner LB
    J Infect Dis; 1992 May; 165(5):938-41. PubMed ID: 1533238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effects of recombinant human granulocyte-macrophage colony stimulating factor on in vitro cord blood granulocyte function.
    Frenck RW; Buescher ES; Vadhan-Raj S
    Pediatr Res; 1989 Jul; 26(1):43-8. PubMed ID: 2549492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monocyte-derived macrophage function in HIV-infected subjects: in vitro modulation by rIFN-gamma and rGM-CSF.
    Capsoni F; Minonzio F; Ongari AM; Rizzardi GP; Lazzarin A; Zanussi C
    Clin Immunol Immunopathol; 1992 Feb; 62(2):176-82. PubMed ID: 1730155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal growth of functionally normal and deficient neutrophils from the bone marrow of a patient with variant chronic granulomatous disease. Lack of reconstitution of oxidative burst defect by G-CSF, GM-CSF, and IFN-gamma in vitro.
    Oez S; Birkmann J; Kalden JR
    Ann Hematol; 1993 Jan; 66(1):21-5. PubMed ID: 7679293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lack of effect of granulocyte-macrophage and granulocyte colony-stimulating factors on cultured human endothelial cells.
    Yong K; Cohen H; Khwaja A; Jones HM; Linch DC
    Blood; 1991 Apr; 77(8):1675-80. PubMed ID: 1707693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of three human recombinant hematopoietic growth factors (granulocyte-macrophage colony-stimulating factor, granulocyte colony-stimulating factor, and interleukin-3) on phagocyte oxidative activity.
    Sullivan GW; Carper HT; Mandell GL
    Blood; 1993 Apr; 81(7):1863-70. PubMed ID: 7681704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential responses of fetal, neonatal, and adult myelopoietic progenitors to interferon and tumor necrosis factor.
    Hahn T; Shulman LM; Ben-Hur H; Karov Y; Barak V; Handgretinger R; Barak Y
    Exp Hematol; 1994 Feb; 22(2):114-21. PubMed ID: 8299733
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone marrow progenitors cultured in the presence of granulocyte-macrophage colony-stimulating factor versus macrophage colony-stimulating factor differentiate into macrophages with distinct tumoricidal capacities.
    Falk LA; Hogan MM; Vogel SN
    J Leukoc Biol; 1988 May; 43(5):471-6. PubMed ID: 3131473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of recombinant human granulocyte colony-stimulating factor administration in normal and experimentally infected newborn rats.
    Iguchi K; Inoue S; Kumar A
    Exp Hematol; 1991 Jun; 19(5):352-8. PubMed ID: 1709109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Candidacidal mechanisms in the human neonate. Impaired IFN-gamma activation of macrophages in newborn infants.
    Maródi L; Káposzta R; Campbell DE; Polin RA; Csongor J; Johnston RB
    J Immunol; 1994 Dec; 153(12):5643-9. PubMed ID: 7989763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of rhGM-CSF on macrophage function.
    Jones TC
    Eur J Cancer; 1993; 29A Suppl 3():S10-3. PubMed ID: 8398363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neutrophil and monocyte function by microbicidal cell-kill assay in patients with cancer receiving granulocyte colony-stimulating factor, granulocyte-macrophage colony-stimulating factor, or no cytokine after cytotoxic chemotherapy: a phase II trial.
    Nemunaitis J; Cox J; Meyer W; Courtney A; Hanson T; Green-Weaver C; Agosti J
    Am J Clin Oncol; 1998 Jun; 21(3):308-12. PubMed ID: 9626806
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vitro effects of granulocyte and granulocyte-macrophage colony-stimulating factor on interleukin-3-dependent proliferation of human neonatal circulating progenitor cells.
    Bedford Russell AR; Davies EG; Gibson FM; Gordon-Smith EC
    Pediatr Res; 1995 May; 37(5):630-3. PubMed ID: 7541523
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression by human recombinant gamma interferon of in vitro macrophage nonopsonic and opsonic phagocytosis and killing.
    Speert DP; Thorson L
    Infect Immun; 1991 Jun; 59(6):1893-8. PubMed ID: 1645327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant granulocyte/macrophage colony-stimulating factor activates macrophages to inhibit Trypanosoma cruzi and release hydrogen peroxide. Comparison with interferon gamma.
    Reed SG; Nathan CF; Pihl DL; Rodricks P; Shanebeck K; Conlon PJ; Grabstein KH
    J Exp Med; 1987 Dec; 166(6):1734-46. PubMed ID: 3119762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.